Marketing-authorisation holder · United States
Day One Biopharms
2 medicines in 1 country, as authorisation holder.
Group structure
Part of
DAYPharmaceutical groupOther companies in the group
Iceland1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| OJEMDA100mg · Tablet | Tovorafenib | United States | Marketed | 2024 |
| OJEMDA25mg/ml · For suspension | Tovorafenib | United States | Marketed | 2024 |